CYduct Diagnostics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CYDX research report →
Companywww.solosendoscopy.com
CYduct Diagnostics, Inc. , a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company's products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps.
- CEO
- Dom L. Gatto
- IPO
- 2000
- Employees
- 3
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $3.20M
- P/E
- -8.34
- P/S
- 53.93
- P/B
- -1.07
- EV/EBITDA
- -11.78
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 65.87%
- Op Margin
- -565.29%
- Net Margin
- -646.37%
- ROE
- 13.44%
- ROIC
- 14.74%
Growth & Income
- Revenue
- $70.69K · -16.33%
- Net Income
- $-413,614 · 1.06%
- EPS
- $-0.08 · 1.74%
- Op Income
- $-363,217
- FCF YoY
- 58.83%
Performance & Tape
- 52W High
- $2.90
- 52W Low
- $0.20
- 50D MA
- $0.63
- 200D MA
- $0.55
- Beta
- -0.78
- Avg Volume
- 56
Get TickerSpark's AI analysis on CYDX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CYDX Coverage
We haven't published any research on CYDX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CYDX Report →